7 Days
المصدر:
Los Angeles Times
Obesity drugs show promise for PMOS treatment
Charlotte Touzalin and her mother, Anne Schultz, were diagnosed with polyendocrine metabolic ovarian syndrome (PMOS), a hormonal disorder affecting insulin and testosterone levels. Recent research indicates that GLP-1 medication treatments can improve symptoms such as weight loss, hormone balance, and ovulation in women with PMOS. Despite promising results from studies, insurance coverage remains a barrier, limiting access to these treatments.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading